References
- Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20:e171–e183.
- Matthews A, Haas DM, O’Mathuna DP, et al. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015;CD007575.
- Veenendaal MV, van Abeelen AF, Painter RC, et al. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG 2011;118:1302–1313.
- ACOG Practice Bulletin No. 189: Nausea and vomiting of pregnancy. Obstet Gynecol. 2018;131:e15–e30.
- Trogstad LI, Stoltenberg C, Magnus P, et al. Recurrence risk in hyperemesis gravidarum. BJOG 2005;112:1641–1645.
- Fejzo MS, MacGibbon KW, Romero R, et al. Recurrence risk of hyperemesis gravidarum. J Midwifery Womens Health. 2011;56:132–136.
- Refuerzo JS, Smith JA, Fox AF. UpToDate. Clinical features and evaluation of nausea and vomiting of pregnancy. [cited 24 Sep 2018]. https://www.uptodate.com
- Abramowitz A, Miller ES, Wisner KL. Treatment options for hyperemesis gravidarum. Arch Womens Ment Health. 2017;20:363–372.
- McCarthy FP, Lutomski JE, Greene RA. Hyperemesis gravidarum: current perspectives. Int J Womens Health. 2014;6:719–725.
- Campbell K, Rowe H, Azzam H, et al. The management of nausea and vomiting of pregnancy. J Obstet Gynaecol Can. 2016;38:1127–1137.
- Smith JA, Refuerzo JS, Fox KA. UpToDate. Treatment and outcome of nausea of pregnancy. [cited 29 May 2018]. https://www.uptodate.com
- Royal College of Obstetricians and Gynaecologists. The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69). [cited 21 Jun 2018]. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg69/
- Doxinate for doctors. Doxinate - Prescribing information. [cited 5 Jul 2017]. http://www.doxinate.com/For-Doctors/Doxinate-Prescribing-Information.html
- Inibsa. Summary of Product Characteristics ((SmPC) Cariban 10 mg. [cited 5 Jul 2017]. http://inibsa.com/en
- U.S Food and Drug Administration (FDA). Diclegis - Full prescribing information. [cited 5 Jul 2017]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021876s002lbl.pdf
- Attard CL, Kohli MA, Coleman S, et al. The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am J Obstet Gynecol. 2002;186:S220–S227.
- Mazzotta P, Maltepe C, Navioz Y, et al. Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada. Int J Gynaecol Obstet. 2000;70:359–365.
- Heitmann K, Nordeng H, Havnen GC, et al. The burden of nausea and vomiting during pregnancy: severe impacts on quality of life, daily life functioning and willingness to become pregnant again – results from a cross-sectional study. BMC Preg Childbirth. 2017;17:75.
- Wood H, McKellar LV, Lightbody M. Nausea and vomiting in pregnancy: blooming or bloomin’ awful? A review of the literature. Women Birth. 2013;26:100–104.
- Poursharif B, Korst LM, Fejzo MS, et al. The psychosocial burden of hyperemesis gravidarum. J Perinatol. 2008;28:176–181.
- Mitchell-Jones N, Gallos I, Farren J, et al. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis. BJOG 2017;124:20–30.
- Mazzotta P, Stewart DE, Koren G, et al. Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. J Psychosom Obstet Gynaecol. 2001;22:7–12.
- Poursharif B, Korst LM, Macgibbon KW, et al. Elective pregnancy termination in a large cohort of women with hyperemesis gravidarum. Contraception 2007;76:451–455.
- Christodoulou-Smith J, Gold JI, Romero R, et al. Posttraumatic stress symptoms following pregnancy complicated by hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2011;24:1307–1311.
- Power Z, Thomson AM, Waterman H. Understanding the stigma of hyperemesis gravidarum: qualitative findings from an action research study. Birth 2010;37:237–244.
- Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993;43:245–248.
- Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000;182:931–937.
- Gaardsrud PO. The Norwegian Directorate of Health. Fastlegestatistikk 2017 (In Norwegian). [cited 29 May 2018]. https://helsedirektoratet.no/statistikk-og-analyse/fastlegestatistikk#fastlegestatistikk-2017
- Boelig RC, Barton SJ, Saccone G, et al. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2017;1–14.
- O'Donnell A, McParlin C, Robson SC, et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment. Health Technol Assess. 2016;20:1–268.
- Koren G. Treating morning sickness PRN? Can Fam Physician. 2013;59:150–151.
- European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. [cited 17 Sep 2018]. http://www.ema.europa.eu
- Mazzotta P, Magee L, Koren G. Therapeutic abortions due to severe morning sickness. Unacceptable combination. Can Fam Physician. 1997;43:1055–1057.
- Koren G and Levichek Z. The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk. Am J Obstet Gynecol. 2002;186:S248–S252.
- Ebrahimi N, Maltepe C, Bournissen FG, et al. Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale. J Obstet Gynaecol Can. 2009;31:803–807.
- Birkeland E, Stokke G, Tangvik RJ, et al. Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study. PLoS One 2015;10:e0119962.
- Vikanes AV, Trovik J, Tellum T, et al. Norwegian obstetric guidlines. Veileder i fødselshjelp 2014 - Emesis og hyperemesis gravidarum [Guideline in obstetrics 2014 - Emesis and hyperemesis gravidarum]. [cited 21 Jun 2018]. http://legeforeningen.no/Fagmed/Norsk-gynekologisk-forening/Veiledere/Veileder-i-fodselshjelp-2014/Emesis-og-hyperemesis-gravidarum
- Russell A, Gillespie S, Satya S, et al. Assessing the accuracy of pregnant women in recalling pre-pregnancy weight and gestational weight gain. J Obstet Gynaecol Can. 2013;35:802–809.
- Kjeldgaard HK, Eberhard-Gran M, Benth JS, et al. History of depression and risk of hyperemesis gravidarum: a population-based cohort study. Arch Womens Ment Health. 2017;20:397–404
- Odalovic M, Vezmar Kovacevic S, Nordeng H, et al. Predictors of the use of medications before and during pregnancy. Int J Clin Pharm. 2013;35:408–416.